Tag: artificial intelligence (ai) in biopharmaceuticals market growth

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Artificial Intelligence (AI) In Biopharmaceuticals Market from 2024 to 2033?

The artificial intelligence (AI) in biopharmaceuticals market has expanded rapidly, expected to grow from $1.19 billion in 2023 to $1.59 billion in 2024 at a CAGR of 33.8%. Growth factors include advancements in computational power and precision medicine.

The AI in biopharmaceuticals market is expected to see exponential growth, reaching $4.99 billion by 2028 with a CAGR of 33.1%. Growth drivers include advancements in computational biology and regulatory support. Trends involve AI-driven drug discovery and technological advancements.

Claim Your Free Sample of the Global Artificial Intelligence (AI) In Biopharmaceuticals Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

What Key Factors Are Fueling the Growth of the Artificial Intelligence (AI) In Biopharmaceuticals Market?

The rising prevalence of chronic diseases is projected to enhance the growth of the artificial intelligence (AI) in biopharmaceuticals market. Chronic diseases are long-term health conditions often influenced by lifestyle, aging, genetics, and environmental factors. AI is increasingly utilized in biopharmaceuticals to manage these conditions by analyzing large datasets, recognizing patterns, and personalizing treatments. According to the National Library of Medicine, chronic diseases are predicted to increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Hence, the growing incidence of chronic diseases is driving the AI in biopharmaceuticals market.

What Are the Major Segments of the Artificial Intelligence (AI) In Biopharmaceuticals Market?

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

What New Trends Are Transforming the Artificial Intelligence (AI) In Biopharmaceuticals Market?

Major companies in artificial intelligence (AI) in biopharmaceuticals are developing target and lead identification suite solutions to accelerate drug discovery. In May 2023, Google LLC launched AI-powered tools to aid researchers in predicting protein structures and managing genomic data, streamlining drug development processes.

Order Now for Fast Delivery of Your Artificial Intelligence (AI) In Biopharmaceuticals Market Report!

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Which Regions Are Driving Growth in the Artificial Intelligence (AI) In Biopharmaceuticals Market?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Artificial Intelligence (AI) In Biopharmaceuticals Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the artificial intelligence (ai) in biopharmaceuticals market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Artificial Intelligence (AI) In Biopharmaceuticals Market Include

1. Artificial Intelligence (AI) In Biopharmaceuticals Market Executive Summary

2. Artificial Intelligence (AI) In Biopharmaceuticals Market Segments

3. Artificial Intelligence (AI) In Biopharmaceuticals Market Size And Template Market Growth Rate

4. Key Artificial Intelligence (AI) In Biopharmaceuticals Market Trends

5. Major Artificial Intelligence (AI) In Biopharmaceuticals Market Drivers

……

25. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Biopharmaceuticals Market

26. Top Artificial Intelligence (AI) In Biopharmaceuticals Companies

27. Artificial Intelligence (AI) In Biopharmaceuticals Market Opportunities And Strategies

28. Artificial Intelligence (AI) In Biopharmaceuticals Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Artificial Intelligence AI In Agriculture Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-agriculture-global-market-report

Artificial Intelligence In Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

Artificial Intelligence In Cardiology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cardiology-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Artificial Intelligence (AI) In Biopharmaceuticals Global Market Report 2024, the artificial intelligence (AI) in biopharmaceuticals market is expected to show significant growth in the forecast period.

• Exponential Market Growth: The artificial intelligence (AI) in biopharmaceuticals market has experienced significant growth, expanding from $1.19 billion in 2023 to a projected $1.59 billion in 2024. This growth, marked by a compound annual growth rate (CAGR) of 33.8%, is driven by advancements in computational power, the explosion of biomedical data, the precision medicine paradigm, and regulatory support.
• Future Market Projections: The market is expected to continue its upward trajectory, reaching $4.99 billion by 2028 with a CAGR of 33.1%. This anticipated growth is attributed to advancements in computational biology, the integration of multi-modal data, the convergence of AI and life sciences, and the establishment of regulatory frameworks emphasizing ethical and fair AI principles.

Chronic Disease Prevalence Driving Market Expansion

• Impact of Chronic Diseases: The increasing prevalence of chronic diseases is a significant factor fueling the growth of AI in biopharmaceuticals. These long-lasting conditions, often resulting from lifestyle factors, aging populations, and genetic predispositions, require sophisticated tools for management. AI’s ability to analyze large datasets, identify patterns, and personalize treatments makes it an invaluable resource in managing chronic diseases.
• Future Projections: According to the National Library of Medicine, the number of chronic disease cases is expected to surge by 99.5% by 2050. This trend underscores the growing need for AI-driven solutions in the biopharmaceutical industry to address the rising demand for effective chronic disease management.

View More On The Artificial Intelligence (AI) In Biopharmaceuticals Market Report 2024 – https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Advancements in AI-Powered Drug Discovery and Precision Medicine

• Innovative AI Solutions: Leading companies in the AI in biopharmaceuticals market are developing advanced AI-powered tools for drug discovery and precision medicine. These solutions aim to streamline the drug development process, reduce costs, and bring new treatments to market faster.
• Case Study – Google LLC: In May 2023, Google launched AI-powered tools designed to predict and understand protein structures, a crucial aspect of drug development. These tools also enable researchers to manage and analyze vast amounts of genomic data, facilitating the advancement of precision medicine. Such innovations are poised to revolutionize life sciences and improve patient outcomes.

ZS Associates’ Acquisition of Trials.ai Inc.

• Strategic Acquisition: In February 2023, ZS Associates acquired Trials.ai Inc. to enhance the design of clinical trials using AI. This acquisition aims to optimize trial speed, improve participant experiences, and expedite the delivery of pharmaceutical therapies to the market.
• Focus on AI in Clinical Trials: Trials.ai Inc. specializes in leveraging AI and machine learning technologies to revolutionize clinical trials. The integration of these technologies is expected to streamline trial processes, making them more efficient and effective.

Regional Market Insights and Segmentation

• Regional Growth: North America led the AI in biopharmaceuticals market in 2023, with Asia-Pacific expected to be the fastest-growing region in the coming years. This growth is driven by the rapid adoption of AI technologies and the increasing demand for innovative biopharmaceutical solutions.
• Market Segmentation: The AI in biopharmaceuticals market is segmented by offering (hardware, software, services), deployment (cloud, on-premises), technology (machine learning, natural language processing, deep learning), application (business process and supply chain, drug discovery, medical imaging, diagnostics, precision medicine), and end-users (manufacturers, contract research organizations, academic and government research institutes).

Conclusion

• Future Outlook: The artificial intelligence in biopharmaceuticals market is set for continued exponential growth, driven by technological advancements, the increasing prevalence of chronic diseases, and strategic industry collaborations. With AI playing a pivotal role in transforming drug discovery, precision medicine, and clinical trials, the market’s potential for innovation and improved patient outcomes is immense.

Request A Sample Of The Global Artificial Intelligence (AI) In Biopharmaceuticals Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=14251&type=smp